Following their triumph at the 36th National Student Scientific Week (Pimnas) in the category of the Student Creativity Program on Creative Initiatives (PKM-KC) in 2023, the Hemoglobest Team at Institut Teknologi Sepuluh Nopember (ITS) received an encouraging development: they were contacted by STMicroelectronics (STM). STMicroelectronics is a global high-tech company creating semiconductor technologies for various industries, who saw potential in the Hemoglobest innovation. They reached out to the Hemoglobest Team following their success story at Pimnas. This partnership prospect signifies a remarkable opportunity for Hemoglobest to advance its technology and potentially bring it to a wider audience.
Under the mentorship of Dr. Astria Nur Irfansyah, a senior lecturer in the Department of Electrical Engineering, the team had successfully developed a pioneering hemoglobin detector named Hemoglobest. With a primary focus on lupus, an autoimmune disease associated with adverse effects like anemia, the Hemoglobest Team’s initiative aimed to introduce a non-invasive hemoglobin detector. This device, driven by artificial intelligence, facilitated the measurement of hemoglobin levels and predicted the likelihood of anemia without invasive procedures. Its non-invasive nature ensured ease of use and eliminated user discomfort. The operational mechanism involved the utilization of five light spectrums absorbed by hemoglobin in the blood vessels of the fingertips, surpassing traditional oximeters that typically rely on only two spectrums.
By employing an STM32 microcontroller, STMicroelectronics could enhance the capabilities of Hemoglobest. The STM32 microcontroller, known for its efficiency and advanced features, seamlessly integrated artificial intelligence functions into the device. This not only conserved power but also served as an early warning system for lupus patients. Moreover, the non-invasive design aimed to reduce medical waste associated with conventional procedures, offering a sustainable solution for patients. The potential impact of Hemoglobest on minimizing medical waste in Indonesia is significant, and with the collaboration with STMicroelectronics, its reach and effectiveness may be further amplified.